|
⚲
|
| Keyboard |
| Kaplan Matthew L
✚
|
|
|---|---|
| CIK # | 0001895952 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001895952] | |
| 4 | [0001895952] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nuvectis Pharma Inc | |
| Kaplan Matthew L |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Nuvectis Pharma Inc NVCT
Common Stock
|
2025-11-05 | Buy | 11,000 | $5.84 | 64,240 |
|
Nuvectis Pharma Inc NVCT
Common Stock
|
2025-06-12 | Grant | 30,000 | $0.00 | |
|
Nuvectis Pharma Inc NVCT
Common Stock
|
2024-06-13 | Grant | 30,000 | $0.00 | |
|
Nuvectis Pharma Inc NVCT
Common Stock
|
2023-06-16 | Grant | 18,000 | $0.00 | |
|
Nuvectis Pharma Inc NVCT
Common Stock
|
2022-05-12 | Buy | 1,823 | $17.47 | 31,848 |
|
Nuvectis Pharma Inc NVCT
Common Stock
|
2022-05-12 | Buy | 1,177 | $15.96 | 18,785 |
|
Nuvectis Pharma Inc NVCT
Stock Options (right to buy) · derivative
|
2022-04-01 | Grant | 15,000 | $0.00 |